Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 11 hours ago
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation: 15/09/2016, Revision: 12, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation...
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Date of authorisation...
Regulatory Perspectives on Herbal Medicinal Botanical Drug Product Development - Joint FDA-EMA Workshop: Event agenda
about 11 hours ago
Regulatory Perspectives on Herbal Medicinal Botanical Drug Product Development - Joint FDA-EMA...
Human medicines European public assessment report (EPAR): Onpattro, patisiran, Date of authorisation: 27/08/2018, Revision: 16, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Onpattro, patisiran, Date of authorisation...
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 22, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation...
Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 13, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan)...
Human medicines European public assessment report (EPAR): Elahere, mirvetuximab soravtansine, Date of authorisation: 14/11/2024, Revision: 3, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Elahere, mirvetuximab soravtansine, Date of...
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 6, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation...
Summary of opinion: Pepaxti, 17/09/2026 Positive
3 days ago
Summary of opinion: Pepaxti, 17/09/2026 Positive
Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
about 16 hours ago
Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
Data Analysis and Real World Interrogation Network (DARWIN EU)
about 16 hours ago
Data Analysis and Real World Interrogation Network (DARWIN EU)